Orthofix Investor Presentation Deck

SeaSpine Q4 and FY 2022 Highlights $237.5M Full Year 2022 Revenue 24% Increase YoY $58.1M Q4 2022 U.S. Revenue 16% Increase YoY $27.5M Q4 2022 U.S. Orthobiologics Revenue 20% Increase YoY ©2023 Orthofix Medical Inc. All rights reserved | 14 $63.4M Q4 2022 Revenue 14% Increase YoY $30.6M Q4 2022 U.S. Spinal Implants & Enabling Technologies Revenue 12% Increase YoY 62.5% 64.0% Gross Margin GAAP Adjusted ORTHOFIX® SeaSpine

View entire presentation